51 research outputs found
SMM885400 Supplementary material - Supplemental material for Sampling-based Markov regression model for multistate disease progression: Applications to population-based cancer screening program
Supplemental material, SMM885400 Supplementary material for Sampling-based Markov regression model for multistate disease progression: Applications to population-based cancer screening program by Chen-Yang Hsu, Wen-Feng Hsu, Amy Ming-Fang Yen and Hsiu-Hsi Chen in Statistical Methods in Medical Research</p
Additional file 1 of Fear of falling as a mediator in the association between social frailty and health-related quality of life in community-dwelling older adults
Additional file 1: Sup_Table 1. Mediation Analyses: Unstandardized Regression Coefficients. Sup_Table 2. Mediation Analyses: Unstandardized Regression Coefficients of Covariates
Additional file 1 of Advancing screening tool for hospice needs and end-of-life decision-making process in the emergency department
Supplementary Material 1: Descriptive data of Taipei City Hospital's Branches and the Original and Modified Risk Score
Cox proportional hazards regression analysis for all-cause mortality.
<p>Abbreviation: CVD, cardiovascular disease; BP, blood pressure; RAS, renin-angiotensin system; iPTH, intact parathyroid hormone; Ca, calcium; P, phosphate; PAOD, peripheral arterial occlusion disease.</p><p>Cox proportional hazards regression analysis for all-cause mortality.</p
Characteristics of study population.
<p>Abbreviations: CVD, cardiovascular disease; BP, blood pressure; iPTH, intact parathyroid hormone; Ca, calcium; P, phosphate; ABI, ankle-brachial index; RAS, renin-angiotensin system.</p><p>Characteristics of study population.</p
Additional file 1: of Effectiveness of advice from physician and nurse on smoking cessation stage in Taiwanese male smokers attending a community-based integrated screening program
Implementation procedure and data collection. (DOC 25 kb
Cox proportional hazards regression analysis for cardiovascular mortality.
<p>Abbreviation: CVD, cardiovascular disease; BP, blood pressure; RAS, renin-angiotensin system; PAOD, iPTH, intact parathyroid hormone; Ca, calcium; P, phosphate; peripheral arterial occlusion disease.</p><p>Cox proportional hazards regression analysis for cardiovascular mortality.</p
Probabilities of overall survival according to dominance side of ABI value.
<p>(A) in all patients with log-rank test: χ<sup>2</sup> = 1.32; <i>P</i> = 0.249; (B) in patients without PAOD with log-rank test: χ<sup>2</sup> = 3.47; <i>P</i> = 0.062; (C) in patients with PAOD with log-rank test: χ<sup>2</sup> = 0.20; <i>P</i> = 0.651.</p
Characteristics of patients at inclusion according to the location of PAOD.
<p>Abbreviations: CVD, cardiovascular disease; BP, blood pressure; iPTH, intact parathyroid hormone; Ca, calcium; P, phosphate; RAS, renin-angiotensin system</p><p>*Comparison between all four groups</p><p><sup>#</sup> Comparison between all groups except non-PAOD group.</p><p>Characteristics of patients at inclusion according to the location of PAOD.</p
Kaplan—Meier survival curves.
<p>Probabilities of (A) overall survival with log-rank test: χ<sup>2</sup> = 60.89; <i>P</i> ≤ 0.001 in the four groups and χ<sup>2</sup> = 2.02; <i>P</i> = 0.364 in the three PAOD groups. (B) Cardiovascular survival with log-rank test: χ<sup>2</sup> = 45.24; <i>P</i> ≤ 0.001 in the four groups and χ<sup>2</sup> = 0.69; <i>P</i> = 0.708 in the three PAOD groups.</p
- …